COTAREG Side Effects

6843807-3 | Face Oedema, Laryngeal Oedema, Overweight, Urticaria
on Jul 01, 2010 Male patient from FRANCE , weighting 260.1 lb, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, laryngeal oedema, overweight, urticaria. Cotareg dosage: 160/25 Mg. During the same period patient was treated with CALDINE (6 Mg, Daily) (View Caldine Review and Caldine Label ), HYPERIUM (1 Mg, Bid) (View Hyperium Review and Hyperium Label ), GLUCOPHAGE (850 Mg, Bid) (View Glucophage Review and Glucophage Label ), ALDACTONE (50 Mg, Daily) (View Aldactone Review and Aldactone Label ), CELECTOL (100 Mg, Daily) (View Celectol Review and Celectol Label ).

6816483-3 | Laryngeal Oedema, Urticaria
Patient was taking Cotareg (View Usage). Patient had the following side effects: laryngeal oedema, urticaria on Jun 22, 2010 from FRANCE Additional patient health information: Male patient , 75 years of age, was diagnosed with hypertension and. Cotareg dosage: 160/25 Mg. During the same period patient was treated with CALDINE (Unk) (View Caldine Review and Caldine Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

6696914-2 | Blood Osmolarity Decreased, Blood Pressure Fluctuation, C-reactive Protein Increased, Confusional State, Fall, Haematoma, Hypokalaemia, Hyponatraemia, Musculoskeletal Pain
Adverse event was reported on Apr 14, 2010 by a Female patient taking Cotareg (View Usage) (Dosage: 1 Df, Qd) was diagnosed with hypertension, nocturia and. Location: FRANCE , weighting 92.59 lb, After Cotareg was administered, patient had the following side effects: blood osmolarity decreased, blood pressure fluctuation, c-reactive protein increased, confusional state, fall (What is fall?), haematoma, hypokalaemia, hyponatraemia, musculoskeletal pain. During the same period patient was treated with DESMOPRESSIN ACETATE (60 Ug, Qd) (View Desmopressin Acetate Review and Desmopressin Acetate Label ), KARDEGIC (160 Mg, Qd) (View Kardegic Review and Kardegic Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), NOCTRAN (5 Mg Daily) (View Noctran Review and Noctran Label ), CODOLIPRANE (1 Df, Qd) (View Codoliprane Review and Codoliprane Label ), SERESTA (View Seresta Review and Seresta Label ), CALCIPRAT (View Calciprat Review and Calciprat Label ). Patient was hospitalized.

6679040-8 | Clonus
on Apr 01, 2010 Male patient from ITALY , 57 years of age, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: clonus. Cotareg dosage: . During the same period patient was treated with LOBIVON (View Lobivon Review and Lobivon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).


6645889-0 | Blood Pressure Abnormal, Cerebrovascular Accident, Fall, Hypokalaemia, Hypokinesia, Hyponatraemia, Loss Of Consciousness, Malaise, Vomiting
on Mar 11, 2010 Female patient from FRANCE , 86 years of age, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient had the following side effects: blood pressure abnormal, cerebrovascular accident, fall (What is fall?), hypokalaemia, hypokinesia, hyponatraemia, loss of consciousness, malaise, vomiting. Cotareg dosage: 160/12.5 Mg Once Daily. During the same period patient was treated with DISCOTRINE (View Discotrine Review and Discotrine Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LEVOTHYROX (50 Ug, Unk) (View Levothyrox Review and Levothyrox Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6606446-5 | Agitation, Anaemia Macrocytic, Asthenia, Decreased Appetite, Erosive Duodenitis, Gamma-glutamyltransferase Abnormal, Haemoglobin Decreased, Hepatomegaly
Patient was taking Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: agitation, anaemia macrocytic, asthenia, decreased appetite, erosive duodenitis, gamma-glutamyltransferase abnormal, haemoglobin decreased, hepatomegaly on Feb 15, 2010 from FRANCE Additional patient health information: Male patient , 47 years of age, was diagnosed with hypertension and. Cotareg dosage: 1 Df, Daily. During the same period patient was treated with AVLOCARDYL (160 Mg, Unk) (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

6406228-3 | Apraxia, Confusional State, Dehydration, Disorientation, Dysstasia, Fatigue, Hallucination, Visual, Hypokalaemia, Hyponatraemia
Adverse event was reported on Oct 05, 2009 by a Female patient taking Cotareg (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: FRANCE , 81 years of age, Patient experienced the following unwanted or unexpected effects: apraxia, confusional state, dehydration, disorientation, dysstasia, fatigue, hallucination, visual, hypokalaemia, hyponatraemia. Patient was hospitalized.

6377876-4 | Angioedema, Dysphagia, Face Oedema, Joint Swelling, Oedema Genital, Oedema Peripheral, Respiratory Distress, Urticaria
on Sep 15, 2009 Male patient from FRANCE , weighting 189.6 lb, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient had the following side effects: angioedema, dysphagia, face oedema, joint swelling, oedema genital, oedema peripheral, respiratory distress, urticaria. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with TAHOR (1 Df, Qd) (View Tahor Review and Tahor Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ).

6346289-3 | Feeling Abnormal, Hyponatraemia, Hypoxia, Joint Injury, Skeletal Injury
on Aug 28, 2009 Female patient from FRANCE , 77 years of age, was diagnosed with hypertension, anxiety (What is anxiety?) and was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: feeling abnormal, hyponatraemia, hypoxia, joint injury, skeletal injury. Cotareg dosage: Unk. During the same period patient was treated with PROCORALAN (Unk) (View Procoralan Review and Procoralan Label ), ESCITALOPRAM (1 Df, Qd) (View Escitalopram Review and Escitalopram Label ), NICARDIPINE HYDROCHLORIDE (Unk) (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

6250027-2 | Gynaecomastia, Surgery
Patient was taking Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: gynaecomastia, surgery (What is surgery?) on Jun 18, 2009 from FRANCE Additional patient health information: Male patient , weighting 244.7 lb, was diagnosed with hypertension, hypercholesterolaemia, type 2 diabetes mellitus and. Cotareg dosage: 80 Mg/12.5 Mg, Qd. During the same period patient was treated with TAHOR (Unk) (View Tahor Review and Tahor Label ), AVANDAMET (Unk) (View Avandamet Review and Avandamet Label ).

6233520-8 | Breast Operation, Gynaecomastia
Adverse event was reported on Jun 05, 2009 by a Male patient taking Cotareg (View Usage) (Dosage: 80 Mg/12.5 Mg) . Location: FRANCE , 58 years of age, Patient had the following side effects: breast operation, gynaecomastia. During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), AVANDAMET (View Avandamet Review and Avandamet Label ).

6173784-2 | Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, Dehydration, Diarrhoea, Gastroenteritis Viral, Hypokalaemia, Renal Failure Acute, Vomiting
on Apr 22, 2009 Male patient from FRANCE , 78 years of age, was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: blood creatinine increased, blood pressure decreased, blood urea increased, dehydration, diarrhoea, gastroenteritis viral, hypokalaemia, renal failure acute, vomiting. Cotareg dosage: Unk. Patient was hospitalized.

6154802-4 | Cholecystectomy, Lipase Increased, Pancreatitis Acute
on Apr 07, 2009 Female patient from FRANCE , 77 years of age, was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystectomy, lipase increased, pancreatitis acute. Cotareg dosage: 160 Mg/12.5 Mg Tablet Daily. Patient was hospitalized.

6126814-8 | Dizziness, Fatigue, Hypogammaglobulinaemia, Mycoplasma Infection, Pallor, Pyrexia
Patient was taking Cotareg (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fatigue, hypogammaglobulinaemia, mycoplasma infection, pallor, pyrexia on Mar 11, 2009 from FRANCE Additional patient health information: Female patient , 47 years of age, was diagnosed with hypertension and. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with CHLORMADINONE ACETATE TAB (View Chlormadinone Acetate Tab Review and Chlormadinone Acetate Tab Label ).

6099957-5 | Blood Cortisol Abnormal, Dizziness, Hyponatraemia, Treatment Noncompliance
Adverse event was reported on Feb 16, 2009 by a Female patient taking Cotareg (View Usage) (Dosage: 80/12.5 Mg Daily) . Location: FRANCE , 78 years of age, After Cotareg was administered, patient had the following side effects: blood cortisol abnormal, dizziness (What is dizziness?), hyponatraemia, treatment noncompliance. During the same period patient was treated with MIOREL (2 Df, Bid) (View Miorel Review and Miorel Label ), PAROXETINE HCL (20 Mg Daily) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ESOMEPRAZOLE (1 Df Daily) (View Esomeprazole Review and Esomeprazole Label ), ACETAMINOPHEN WITH PROPOXYPHENE HCL TAB (2 Df, Tid) (View Acetaminophen With Propoxyphene Hcl Tab Review and Acetaminophen With Propoxyphene Hcl Tab Label ). Patient was hospitalized.

5936092-8 | Cortisol Free Urine Decreased, Dyspnoea Exertional, Gait Disturbance, Hormone Level Abnormal, Hypertriglyceridaemia, Lipoma, Lipoma Excision, Mobility Decreased, Surgery
on Oct 23, 2008 Female patient from FRANCE , 63 years of age, weighting 136.7 lb, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: cortisol free urine decreased, dyspnoea exertional, gait disturbance, hormone level abnormal, hypertriglyceridaemia, lipoma, lipoma excision, mobility decreased, surgery (What is surgery?). Cotareg dosage: 1 Df, Qd. During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ). Patient was hospitalized.

5934299-7 | Blood Pressure Systolic Decreased, Intentional Overdose, Suicide Attempt
on Oct 20, 2008 Female patient from FRANCE , 35 years of age, was treated with Cotareg (View Usage). Patient had the following side effects: blood pressure systolic decreased, intentional overdose, suicide attempt. Cotareg dosage: 50 Tablets In One Intake. Patient was hospitalized.

5814433-X | Blood Creatinine Increased, Cardiac Disorder, Hyperkalaemia, Renal Failure
Patient was taking Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: blood creatinine increased, cardiac disorder, hyperkalaemia, renal failure on Jul 09, 2008 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with hypertension, anxiety (What is anxiety?) and. Cotareg dosage: 80 Mg, Qd. During the same period patient was treated with TARKA (1 Df, Qd) (View Tarka Review and Tarka Label ), ACEBUTOLOL (100 Mg, Qd) (View Acebutolol Review and Acebutolol Label ), PRAVADUAL (1 Df, Qd) (View Pravadual Review and Pravadual Label ), TEMESTA (1 Mg, Qd) (View Temesta Review and Temesta Label ). Patient was hospitalized.

5703693-1 | Bronchitis, Tendon Rupture
Adverse event was reported on Apr 03, 2008 by a Male patient taking Cotareg (View Usage) (Dosage: ) was diagnosed with aortic valve disease, bronchitis (What is bronchitis?), angina pectoris, dysuria and. Location: FRANCE , 77 years of age, Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), tendon rupture. During the same period patient was treated with CELESTONE (6 Mg, Qd) (View Celestone Review and Celestone Label ), ROXITHROMYCINE (300 Mg, Qd) (View Roxithromycine Review and Roxithromycine Label ), TOPLEXIL (View Toplexil Review and Toplexil Label ), CRESTOR (View Crestor Review and Crestor Label ), DISCOTRINE (10 Mg, Qd) (View Discotrine Review and Discotrine Label ), AMLOR (5 Mg, Qd) (View Amlor Review and Amlor Label ), XATRAL (10 Mg, Qd) (View Xatral Review and Xatral Label ), KARDEGIC (1 Df, Qd) (View Kardegic Review and Kardegic Label ).

5657901-6 | Ageusia
on Feb 26, 2008 Female patient from FRANCE , 60 years of age, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient had the following side effects: ageusia. Cotareg dosage: 1 Df, Qd.

5653924-1 | Blood Creatinine Increased, Blood Urea Increased, Cerebrovascular Accident, Creatinine Renal Clearance Decreased, Dehydration, Proteinuria, Renal Failure Acute
on Mar 03, 2008 Female patient from FRANCE , 83 years of age, was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: blood creatinine increased, blood urea increased, cerebrovascular accident, creatinine renal clearance decreased, dehydration, proteinuria, renal failure acute. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with LASILIX (40 Mg/day) (View Lasilix Review and Lasilix Label ), PREVISCAN (View Previscan Review and Previscan Label ), TRINIPATCH (View Trinipatch Review and Trinipatch Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

5621613-5 | Thrombocytopenia, Vaginal Haemorrhage
Patient was taking Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia, vaginal haemorrhage on Feb 01, 2008 from TUNISIA Additional patient health information: Female patient , 55 years of age, was diagnosed with hypertension and. Cotareg dosage: 160 Mg/day.

5592841-2 | Angina Pectoris, Bradycardia, Chest Discomfort, Dizziness, Insomnia, Nausea, Palpitations, Syncope Vasovagal
Adverse event was reported on Jan 14, 2008 by a Female patient taking Cotareg (View Usage) (Dosage: 0.5 Df, Qd) was diagnosed with hypertension and. Location: FRANCE , 46 years of age, weighting 134.5 lb, Patient had the following side effects: angina pectoris, bradycardia, chest discomfort, dizziness (What is dizziness?), insomnia, nausea (What is nausea?), palpitations, syncope vasovagal. During the same period patient was treated with NUTRITION SUPPLEMENTS (View Nutrition Supplements Review and Nutrition Supplements Label ).

5458085-X | Erythema, Pemphigoid, Pruritus
on Sep 13, 2007 Female patient from FRANCE , 78 years of age, was diagnosed with hypertension, hypothyroidism, venous stasis, dyslipidaemia, osteoarthritis (What is osteoarthritis?) and was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: erythema, pemphigoid, pruritus. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), DAFLON (6 Tabs/day) (View Daflon Review and Daflon Label ), LIPANTHYL (145 Mg, Qd) (View Lipanthyl Review and Lipanthyl Label ), TANAKAN (40 Mg, Tid) (View Tanakan Review and Tanakan Label ), ART 50 (50 Mg, Bid) (View Art 50 Review and Art 50 Label ). Patient was hospitalized.

5413217-4 | Erythema, Pemphigoid, Pruritus
on Aug 09, 2007 Female patient from FRANCE , 78 years of age, was diagnosed with hypertension, hypothyroidism, venous stasis, dyslipidaemia, osteoarthritis (What is osteoarthritis?) and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, pemphigoid, pruritus. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DAFLON (6 Tabs/day) (View Daflon Review and Daflon Label ), LIPANTHYL (145 Mg, Qd) (View Lipanthyl Review and Lipanthyl Label ), TANAKAN (40 Mg, Tid) (View Tanakan Review and Tanakan Label ), ART 50 (50 Mg, Bid) (View Art 50 Review and Art 50 Label ). Patient was hospitalized.

5405630-6 | Breast Cancer
Patient was taking Cotareg (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Jul 27, 2007 from FRANCE Additional patient health information: Female patient , 83 years of age, weighting 105.8 lb, was diagnosed with hypertension and. Cotareg dosage: . During the same period patient was treated with NEBIVOLOL (TEMERIT) (View Nebivolol (temerit) Review and Nebivolol (temerit) Label ).

5391167-X | Bone Marrow Failure, Leukopenia, Platelet Count Decreased, Red Blood Cell Count Decreased
Adverse event was reported on Jul 11, 2007 by a Female patient taking Cotareg (View Usage) (Dosage: 1 Df, Qd) was diagnosed with hypertension and. Location: FRANCE , 65 years of age, After Cotareg was administered, patient had the following side effects: bone marrow failure, leukopenia, platelet count decreased, red blood cell count decreased. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

5388918-7 | Erythema, Pemphigoid, Pruritus
on Jul 09, 2007 Female patient from FRANCE , 78 years of age, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, pemphigoid, pruritus. Cotareg dosage: 1 Df, Qd. Patient was hospitalized.

5378160-8 | Microalbuminuria
on Jun 27, 2007 Female patient from FRANCE , 58 years of age, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient had the following side effects: microalbuminuria. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), TENORDATE (View Tenordate Review and Tenordate Label ).

5361547-7 | Bone Marrow Failure, Leukopenia, Platelet Count Decreased, Red Blood Cell Count Decreased
Patient was taking Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: bone marrow failure, leukopenia, platelet count decreased, red blood cell count decreased on Jun 12, 2007 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with hypertension and. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

5343528-2 | Amnesia, Dizziness, Impaired Driving Ability, Malaise, Presyncope
Adverse event was reported on May 26, 2007 by a Female patient taking Cotareg (View Usage) (Dosage: 1 Df, Qd) was diagnosed with hypertension and. Location: FRANCE , 73 years of age, Patient experienced the following unwanted or unexpected effects: amnesia, dizziness (What is dizziness?), impaired driving ability, malaise, presyncope. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ).

5323477-6 | Cough, Dyspnoea, Pulmonary Fibrosis, Silicosis, Staphylococcal Infection
on May 09, 2007 Female patient from FRANCE , 86 years of age, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Cotareg (View Usage). Patient had the following side effects: cough, dyspnoea, pulmonary fibrosis (What is pulmonary fibrosis?), silicosis, staphylococcal infection (What is staphylococcal infection?). Cotareg dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

5317614-7 | Autoimmune Disorder, Erythema, Vasculitis
on Apr 26, 2007 Female patient from FRANCE , 61 years of age, was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: autoimmune disorder, erythema, vasculitis (What is vasculitis?). Cotareg dosage: 1 Df, Qd.

5291684-7 | Epilepsy, Hyponatraemia
Patient was taking Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?), hyponatraemia on Mar 29, 2007 from FRANCE Additional patient health information: Female patient , 76 years of age, was diagnosed with hypertension and. Cotareg dosage: 160/12.5 Mg. During the same period patient was treated with NEBIVOLOL (TEMERIT) (View Nebivolol (temerit) Review and Nebivolol (temerit) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DEROXAT (View Deroxat Review and Deroxat Label ). Patient was hospitalized.

5269541-1 | Abortion Induced, Kidney Enlargement, Oligohydramnios, Pregnancy, Pulmonary Malformation, Renal Failure, Skull Malformation, Ultrasound Kidney Abnormal
Adverse event was reported on Mar 12, 2007 by a Female patient taking Cotareg (View Usage) (Dosage: ) was diagnosed with arterial disorder and. Location: FRANCE , 35 years of age, Patient had the following side effects: abortion induced, kidney enlargement, oligohydramnios, pregnancy (What is pregnancy?), pulmonary malformation, renal failure, skull malformation, ultrasound kidney abnormal. During the same period patient was treated with COAPROVEL (View Coaprovel Review and Coaprovel Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), ZOCOR (View Zocor Review and Zocor Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), GINKOR FORT (View Ginkor Fort Review and Ginkor Fort Label ).

5262205-X | Abdominal Mass, Abdominal Pain, Bradycardia, Bronchitis, Dyspnoea, Fall, Haemoglobin Decreased, Hypokalaemia, Hyponatraemia
on Feb 26, 2007 Female patient from FRANCE , 86 years of age, weighting 121.3 lb, was diagnosed with hypertension and was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: abdominal mass, abdominal pain (What is abdominal pain?), bradycardia, bronchitis (What is bronchitis?), dyspnoea, fall (What is fall?), haemoglobin decreased, hypokalaemia, hyponatraemia. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with DIGOXIN (1 Df, Qd) (View Digoxin Review and Digoxin Label ), CORTANCYL (20 Mg, Tid) (View Cortancyl Review and Cortancyl Label ), PREVISCAN (0.5 Df, Qd) (View Previscan Review and Previscan Label ), FLECAINIDE ACETATE (100 Mg, Qd) (View Flecainide Acetate Review and Flecainide Acetate Label ), HEMIGOXINE (1 Df, Qd) (View Hemigoxine Review and Hemigoxine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), CELECTOL (View Celectol Review and Celectol Label ). Patient was hospitalized.

5228283-9 | Asthma Late Onset, Erythema, Rhinitis
on Jan 23, 2007 Male patient from FRANCE , 64 years of age, was diagnosed with hypertension and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: asthma late onset, erythema, rhinitis. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with SYMBICORT (2 Df, Qd) (View Symbicort Review and Symbicort Label ), SINGULAIR (View Singulair Review and Singulair Label ).

5165318-6 | Autoimmune Disorder, Dermatitis Bullous, Pruritus, Skin Lesion
Patient was taking Cotareg (View Usage). Patient had the following side effects: autoimmune disorder, dermatitis bullous, pruritus, skin lesion on Oct 04, 2006 from FRANCE Additional patient health information: Female patient , 67 years of age, . Cotareg dosage: 1 Df, Qd. During the same period patient was treated with PROZAC (20 Mg, Qd) (View Prozac Review and Prozac Label ), EUPRESSYL (60 Mg, Bid) (View Eupressyl Review and Eupressyl Label ), FUROSEMIDE ^DAKOTA PHARM^ (20 Mg, Qd) (View Furosemide ^dakota Pharm^ Review and Furosemide ^dakota Pharm^ Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SINTROM (3 Mg/day) (View Sintrom Review and Sintrom Label ), AVLOCARDYL (20 Mg, Qd) (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

5145841-0 | Blood Creatine Phosphokinase Increased, Cerebral Atrophy, Electroencephalogram Abnormal, Encephalopathy, Epilepsy, Hyponatraemia, Hypotension, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal
Adverse event was reported on Oct 26, 2006 by a Female patient taking Cotareg (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: FRANCE , 73 years of age, After Cotareg was administered, patient had the following side effects: blood creatine phosphokinase increased, cerebral atrophy, electroencephalogram abnormal, encephalopathy, epilepsy (What is epilepsy?), hyponatraemia, hypotension, nervous system disorder, nuclear magnetic resonance imaging abnormal. During the same period patient was treated with BI TILDIEM (View Bi-tildiem Review and Bi-tildiem Label ). Patient was hospitalized.

5127480-0 | Agitation, Amnesia, Bite, Epilepsy, Loss Of Consciousness, Malaise
on Oct 02, 2006 Male patient from FRANCE , 86 years of age, weighting 130.1 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, amnesia, bite, epilepsy (What is epilepsy?), loss of consciousness, malaise. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with GARDENAL (0.5 Tab Every 4 Days) (View Gardenal Review and Gardenal Label ), HEMI DAONIL (1 Df, Qd) (View Hemi-daonil Review and Hemi-daonil Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), TENORDATE (1 Df, Qd) (View Tenordate Review and Tenordate Label ), OMIX (1 Df, Qd) (View Omix Review and Omix Label ). Patient was hospitalized.

5106251-5 | Agitation, Delusion, Eating Disorder, Emotional Disorder, Incoherent, Insomnia, Suspiciousness
on Sep 08, 2006 Female patient from FRANCE , 77 years of age, was diagnosed with hypertension, dyslipidaemia and was treated with Cotareg (View Usage). Patient had the following side effects: agitation, delusion, eating disorder (What is eating disorder?), emotional disorder, incoherent, insomnia, suspiciousness. Cotareg dosage: 1 Tablet Daily. During the same period patient was treated with STILNOX (View Stilnox Review and Stilnox Label ), LIPANOR (100 Mg, Qd) (View Lipanor Review and Lipanor Label ), METFORMIN HCL (1700 Mg Daily) (View Metformin Hcl Review and Metformin Hcl Label ), EFFEXOR (View Effexor Review and Effexor Label ). Patient was hospitalized.

5051055-5 | Dizziness, Fatigue, Malaise, Sense Of Oppression
Patient was taking Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, malaise, sense of oppression on Jul 03, 2006 from FRANCE Additional patient health information: Female patient , 52 years of age, was diagnosed with hypertension, back pain (What is back pain?) and. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with NEXEN (Unk, Unk) (View Nexen Review and Nexen Label ).

5042349-8 | Psoriasis
Adverse event was reported on Jun 26, 2006 by a Female patient taking Cotareg (View Usage) (Dosage: ) was diagnosed with essential hypertension, depression (What is depression?), sleep disorder (What is sleep disorder?), anxiety (What is anxiety?) and. Location: FRANCE , 84 years of age, Patient experienced the following unwanted or unexpected effects: psoriasis. During the same period patient was treated with SOTALOL HCL (80 Mg, Qd) (View Sotalol Hcl Review and Sotalol Hcl Label ), MIANSERIN (60 Mg/day) (View Mianserin Review and Mianserin Label ), AERIUS (View Aerius Review and Aerius Label ), NOCTRAN 10 (View Noctran 10 Review and Noctran 10 Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ). Patient was hospitalized.

5025616-3 | Asthenia, Atrial Fibrillation, Blood Sodium Decreased, Cardiac Murmur, Dyspnoea Exertional, Electrocardiogram Abnormal, Heart Rate Irregular, Hyponatraemia, Nausea
on Mar 17, 2006 Female patient from FRANCE , 73 years of age, weighting 156.5 lb, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Cotareg (View Usage). Patient had the following side effects: asthenia, atrial fibrillation (What is atrial fibrillation?), blood sodium decreased, cardiac murmur, dyspnoea exertional, electrocardiogram abnormal, heart rate irregular, hyponatraemia, nausea (What is nausea?). Cotareg dosage: 1 Df, Qd. During the same period patient was treated with KERLONE (1 Df, Qd) (View Kerlone Review and Kerlone Label ), LOXEN LP (50 Mg, Qd) (View Loxen Lp Review and Loxen Lp Label ), FLECAINIDE ACETATE (1 Df, Bid) (View Flecainide Acetate Review and Flecainide Acetate Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

5016552-7 | Paraesthesia, Sjogren's Syndrome
on May 23, 2006 Male patient from FRANCE , 43 years of age, was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: paraesthesia, sjogren's syndrome (What is sjogren's syndrome?). Cotareg dosage: .

4994836-6 | Paraesthesia, Polyneuropathy
Patient was taking Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: paraesthesia, polyneuropathy on Apr 25, 2006 from FRANCE Additional patient health information: Male patient , 61 years of age, was diagnosed with hypertension and. Cotareg dosage: .

4986922-1 | Blood Chromogranin A Increased, Extraocular Muscle Paresis, Fatigue, Headache
Adverse event was reported on Apr 21, 2006 by a Male patient taking Cotareg (View Usage) (Dosage: 1 Df, Qd) was diagnosed with hypertension and. Location: FRANCE , 57 years of age, Patient had the following side effects: blood chromogranin a increased, extraocular muscle paresis, fatigue, headache (What is headache?).

4986921-X | Confusional State, Fall, Hyponatraemia, Loss Of Consciousness, Malaise, Wrist Fracture
on Apr 24, 2006 Female patient from FRANCE , 85 years of age, weighting 119.0 lb, was diagnosed with essential hypertension and was treated with Cotareg (View Usage). After Cotareg was administered, patient had the following side effects: confusional state, fall (What is fall?), hyponatraemia, loss of consciousness, malaise, wrist fracture. Cotareg dosage: 80 Mg/day. During the same period patient was treated with KARDEGIC (160 Mg/day) (View Kardegic Review and Kardegic Label ), MOPRAL (20 Mg/day) (View Mopral Review and Mopral Label ). Patient was hospitalized.

4968674-4 | Polyneuropathy
on Nov 30, 2005 Male patient from FRANCE , 69 years of age, was diagnosed with hypertension, hypercholesterolaemia and was treated with Cotareg (View Usage). Patient experienced the following unwanted or unexpected effects: polyneuropathy. Cotareg dosage: 1 Df, Qd. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ).

4959092-3 | Fall, Hypertension, Loss Of Consciousness, Malaise
Patient was taking Cotareg (View Usage). Patient had the following side effects: fall (What is fall?), hypertension, loss of consciousness, malaise on Mar 23, 2006 from FRANCE Additional patient health information: Female patient , 68 years of age, was diagnosed with hypertension and. Cotareg dosage: 1 Df, Qd.